| Code | Description | Claims | Beneficiaries | Total Paid |
| 80053 |
Comprehensive metabolic panel |
14,805 |
12,026 |
$670K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
4,195 |
3,841 |
$434K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
3,237 |
2,985 |
$420K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,518 |
2,172 |
$370K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
9,155 |
7,004 |
$296K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
7,298 |
1,830 |
$274K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,563 |
1,344 |
$218K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
18,776 |
14,847 |
$129K |
| 36415 |
Collection of venous blood by venipuncture |
14,218 |
11,176 |
$88K |
| 80050 |
General health panel |
1,841 |
1,749 |
$83K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,937 |
1,604 |
$79K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,983 |
3,195 |
$74K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
824 |
724 |
$71K |
| 80061 |
Lipid panel |
4,470 |
4,010 |
$56K |
| 71046 |
Radiologic examination, chest; 2 views |
3,146 |
2,588 |
$53K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,141 |
1,034 |
$51K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,777 |
2,958 |
$47K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,962 |
3,382 |
$46K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
974 |
886 |
$46K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
972 |
884 |
$46K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,476 |
1,104 |
$44K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,137 |
3,599 |
$42K |
| 85027 |
|
6,827 |
5,314 |
$39K |
| 87088 |
|
4,863 |
4,033 |
$39K |
| 81025 |
|
4,177 |
3,722 |
$37K |
| 71045 |
Radiologic examination, chest; single view |
4,984 |
4,070 |
$36K |
| 84484 |
|
4,585 |
3,461 |
$34K |
| 86901 |
|
1,141 |
963 |
$33K |
| 80305 |
|
2,298 |
1,997 |
$32K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,112 |
2,586 |
$29K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,765 |
3,127 |
$29K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
913 |
830 |
$29K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,058 |
945 |
$28K |
| 80076 |
|
1,095 |
951 |
$28K |
| 83880 |
|
1,563 |
1,271 |
$27K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
514 |
502 |
$25K |
| 73560 |
|
767 |
623 |
$25K |
| 82550 |
|
3,789 |
2,989 |
$25K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,003 |
2,710 |
$25K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
627 |
494 |
$22K |
| 81001 |
|
6,979 |
5,892 |
$22K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
526 |
428 |
$21K |
| 87040 |
|
2,542 |
1,422 |
$20K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
207 |
194 |
$20K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
6,757 |
6,087 |
$20K |
| 87070 |
|
1,731 |
1,277 |
$20K |
| 83690 |
|
2,814 |
2,353 |
$20K |
| 83605 |
|
2,042 |
1,500 |
$19K |
| 87077 |
|
2,246 |
1,881 |
$18K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
162 |
147 |
$18K |
| 86900 |
|
1,142 |
964 |
$17K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,264 |
1,025 |
$16K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
85 |
85 |
$16K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,672 |
1,482 |
$15K |
| 97162 |
|
150 |
144 |
$13K |
| 80306 |
|
697 |
570 |
$13K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,169 |
1,760 |
$13K |
| 81003 |
|
6,289 |
5,289 |
$13K |
| 72100 |
|
379 |
340 |
$12K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
62 |
58 |
$12K |
| 82077 |
|
620 |
533 |
$11K |
| 73630 |
|
301 |
259 |
$10K |
| 74018 |
|
537 |
449 |
$10K |
| T1015 |
Clinic visit/encounter, all-inclusive |
874 |
641 |
$10K |
| 87186 |
|
1,964 |
1,634 |
$10K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,812 |
3,054 |
$9K |
| 86803 |
|
424 |
391 |
$8K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
175 |
162 |
$8K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
237 |
214 |
$8K |
| 86780 |
|
420 |
379 |
$8K |
| 83735 |
|
1,573 |
1,298 |
$8K |
| 82150 |
|
1,197 |
1,013 |
$8K |
| 73610 |
|
379 |
306 |
$8K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,281 |
1,049 |
$7K |
| 82803 |
|
366 |
266 |
$7K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
27 |
26 |
$7K |
| 80320 |
|
404 |
334 |
$6K |
| 82607 |
|
408 |
379 |
$6K |
| 85007 |
|
2,071 |
1,614 |
$6K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,649 |
2,162 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,122 |
911 |
$6K |
| 71020 |
|
513 |
372 |
$6K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,584 |
1,251 |
$6K |
| 82962 |
|
1,141 |
565 |
$5K |
| 85610 |
|
1,981 |
1,575 |
$5K |
| 96376 |
|
282 |
206 |
$5K |
| 76830 |
Ultrasound, transvaginal |
74 |
71 |
$5K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
96 |
91 |
$5K |
| 82375 |
|
376 |
286 |
$5K |
| 87340 |
|
336 |
308 |
$5K |
| 86850 |
|
975 |
838 |
$5K |
| 82947 |
|
1,046 |
811 |
$5K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
21 |
14 |
$5K |
| 87631 |
|
64 |
57 |
$4K |
| 73030 |
|
170 |
140 |
$4K |
| 85379 |
|
520 |
476 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
993 |
843 |
$4K |
| 87807 |
|
349 |
309 |
$4K |
| 77080 |
|
80 |
76 |
$4K |
| 86762 |
|
179 |
168 |
$4K |
| 80179 |
|
185 |
165 |
$4K |
| 80329 |
|
214 |
153 |
$3K |
| 80143 |
|
159 |
139 |
$3K |
| 97001 |
|
96 |
83 |
$2K |
| 73130 |
|
78 |
66 |
$2K |
| 82805 |
|
93 |
74 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
179 |
149 |
$2K |
| 85730 |
|
485 |
435 |
$2K |
| 87081 |
|
195 |
171 |
$2K |
| 84436 |
|
209 |
200 |
$2K |
| 87205 |
|
312 |
248 |
$1K |
| 86592 |
|
269 |
239 |
$1K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
27 |
27 |
$1K |
| 71010 |
|
215 |
183 |
$1K |
| 73502 |
|
49 |
38 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
18 |
14 |
$1K |
| 74000 |
|
86 |
58 |
$1K |
| 0353U |
|
494 |
444 |
$919.89 |
| 82677 |
|
27 |
25 |
$863.50 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
89 |
70 |
$803.41 |
| 73110 |
|
27 |
25 |
$791.96 |
| 82570 |
|
165 |
147 |
$756.96 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
60 |
13 |
$708.08 |
| 72040 |
|
33 |
25 |
$691.92 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
903 |
758 |
$659.34 |
| 82105 |
|
27 |
25 |
$598.75 |
| 82728 |
|
46 |
39 |
$588.58 |
| 85055 |
|
42 |
37 |
$573.04 |
| 86336 |
|
27 |
25 |
$544.25 |
| 82248 |
|
87 |
77 |
$528.40 |
| 84702 |
|
51 |
43 |
$519.30 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
16 |
12 |
$512.07 |
| 82247 |
|
78 |
38 |
$473.22 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,093 |
1,526 |
$411.02 |
| 84703 |
|
46 |
41 |
$367.91 |
| 97032 |
|
91 |
26 |
$326.82 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
180 |
155 |
$322.32 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
412 |
318 |
$314.46 |
| 74022 |
|
13 |
12 |
$256.00 |
| J2704 |
Injection, propofol, 10 mg |
309 |
276 |
$235.35 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
14 |
14 |
$227.62 |
| 84550 |
|
54 |
51 |
$215.70 |
| 80349 |
|
15 |
13 |
$213.50 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
529 |
432 |
$207.89 |
| 82043 |
|
39 |
38 |
$185.40 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,000 |
1,543 |
$168.59 |
| 85652 |
|
56 |
51 |
$153.70 |
| 81002 |
|
85 |
67 |
$146.40 |
| 83540 |
|
28 |
24 |
$144.79 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
56 |
42 |
$140.05 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,272 |
950 |
$137.13 |
| 80164 |
|
14 |
12 |
$119.65 |
| 81015 |
|
120 |
109 |
$113.68 |
| 84439 |
|
15 |
14 |
$106.52 |
| 82950 |
|
12 |
12 |
$90.85 |
| J2060 |
Injection, lorazepam, 2 mg |
118 |
96 |
$80.68 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
205 |
162 |
$78.01 |
| 36600 |
|
424 |
329 |
$71.60 |
| 84450 |
|
12 |
12 |
$66.42 |
| A9270 |
Non-covered item or service |
2,760 |
656 |
$53.75 |
| 84100 |
|
16 |
12 |
$40.68 |
| 90686 |
|
21 |
19 |
$36.64 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
18 |
14 |
$29.83 |
| J7050 |
Infusion, normal saline solution, 250 cc |
3,177 |
1,868 |
$28.83 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
32 |
25 |
$20.18 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
76 |
39 |
$9.03 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
30 |
25 |
$5.44 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
64 |
61 |
$4.13 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
275 |
205 |
$0.98 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
110 |
94 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,965 |
2,768 |
$0.00 |
| G0378 |
Hospital observation service, per hour |
29 |
24 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
49 |
26 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
18 |
12 |
$0.00 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
12 |
12 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
19 |
13 |
$0.00 |